These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO, Children's Cancer Group Study 2891. J Clin Oncol; 2003 Sep 15; 21(18):3415-22. PubMed ID: 12885836 [Abstract] [Full Text] [Related]
5. Acute leukemias in children with Down syndrome. Zwaan MC, Reinhardt D, Hitzler J, Vyas P. Pediatr Clin North Am; 2008 Feb 15; 55(1):53-70, x. PubMed ID: 18242315 [Abstract] [Full Text] [Related]
6. Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003. Tandonnet J, Clavel J, Baruchel A, Nacka F, Pérel Y. Pediatr Blood Cancer; 2010 Jul 01; 54(7):927-33. PubMed ID: 20405513 [Abstract] [Full Text] [Related]
7. Optimizing therapy for myeloid disorders of Down syndrome. Webb DK. Br J Haematol; 2005 Oct 01; 131(1):3-7. PubMed ID: 16173956 [Abstract] [Full Text] [Related]
12. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group. Kudo K, Kojima S, Tabuchi K, Yabe H, Tawa A, Imaizumi M, Hanada R, Hamamoto K, Kobayashi R, Morimoto A, Nakayama H, Tsuchida M, Horibe K, Kigasawa H, Tsukimoto I, Japanese Childhood AML Cooperative Study Group. J Clin Oncol; 2007 Dec 01; 25(34):5442-7. PubMed ID: 18048827 [Abstract] [Full Text] [Related]
13. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Kobayashi R, Tawa A, Hanada R, Horibe K, Tsuchida M, Tsukimoto I, Japanese childhood AML cooperative study group. Pediatr Blood Cancer; 2007 Apr 01; 48(4):393-8. PubMed ID: 16550530 [Abstract] [Full Text] [Related]
14. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Creutzig U, Zimmermann M, Lehrnbecher T, Graf N, Hermann J, Niemeyer CM, Reiter A, Ritter J, Dworzak M, Stary J, Reinhardt D. J Clin Oncol; 2006 Sep 20; 24(27):4499-506. PubMed ID: 16983120 [Abstract] [Full Text] [Related]
15. Acute myeloid leukaemia in patients with trisomy 21. Collins KJ. J Paediatr Child Health; 1995 Feb 20; 31(1):57. PubMed ID: 7748694 [No Abstract] [Full Text] [Related]
16. [Diagnostics and therapy of acute myeloid leukemia]. Fritsch S, Metzeler K, Hiddemann W, Buske C. Dtsch Med Wochenschr; 2006 Oct 27; 131(43):2401-6. PubMed ID: 17054056 [No Abstract] [Full Text] [Related]
17. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. Gupta V, Chun K, Yi QL, Minden M, Schuh A, Wells R, Brandwein J. Cancer; 2005 May 15; 103(10):2082-90. PubMed ID: 15830348 [Abstract] [Full Text] [Related]